Prudential Financial’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-10,170
| Closed | -$400K | – | 2740 |
|
|
2023
Q2 | $400K | Sell |
10,170
-10,760
| -51% | -$380K | ﹤0.01% | 2212 |
|
|
2023
Q1 | $509K | Sell |
20,930
-43,645
| -68% | -$956K | ﹤0.01% | 2057 |
|
|
2022
Q4 | $1.38M | Sell |
64,575
-1,652
| -2% | -$35.3K | ﹤0.01% | 1523 |
|
|
2022
Q3 | $1.19M | Buy |
+66,227
| New | +$869K | ﹤0.01% | 1662 |
|
|
2022
Q2 | – | Sell |
-184,410
| Closed | -$3.1M | – | 2782 |
|
|
2022
Q1 | $3.1M | Buy |
+184,410
| New | +$2.73M | ﹤0.01% | 1252 |
|
|
2016
Q4 | – | Sell |
-6,218
| Closed | -$287K | – | 2391 |
|
|
2016
Q3 | $287K | Buy |
6,218
+631
| +11% | +$35.6K | ﹤0.01% | 2145 |
|
|
2016
Q2 | $285K | Buy |
+5,587
| New | +$278K | ﹤0.01% | 2129 |
|
|
2016
Q1 | – | Sell |
-75,800
| Closed | -$5.95M | – | 2336 |
|
|
2015
Q4 | $5.95M | Buy |
75,800
+70,700
| +1,386% | +$4.09M | 0.01% | 1008 |
|
|
2015
Q3 | $207K | Sell |
5,100
-5,300
| -51% | -$281K | ﹤0.01% | 2125 |
|
|
2015
Q2 | $541K | Buy |
+10,400
| New | +$517K | ﹤0.01% | 1945 |
|
Prudential Financial's ISEE Position: Q3 2023 in Review
Prudential Financial sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 10,170 shares — an estimated $400K sold.
Prudential Financial first reported a position in ISEE in Q2 2015 and held it in 10 quarters. The position peaked at $5.95M in Q4 2015. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.
- Prudential Financial reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Prudential Financial sold 10,170 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $400K.
- Prudential Financial first reported a position in IVERIC bio, Inc. Common Stock in Q2 2015 and held it in 10 quarters.
- Prudential Financial's IVERIC bio, Inc. Common Stock position peaked at $5.95M in Q4 2015.
- 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.
Based on Prudential Financial's 13F filing for Q3 2023, filed 13 Nov 2023.